Cannabis Law Report

DECEMBER 15, 2021

Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. The Company is commercialising a range of imported and locally sourced and manufactured medicinal cannabis products.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

MARCH 9, 2022

Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. The Company is commercialising a range of imported and locally sourced and manufactured medicinal cannabis products.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

JUNE 9, 2021

Research indicates that psychedelics have the potential to be a breakthrough in treating PTSD, depression, addiction, and other conditions. The MAPS Corporate Counsel will act as leadership for legal across MAPS and its subsidiaries and is responsible for leading legal initiatives to mitigate risk, ensure compliance and expand opportunities.

Research and Development 76

Research and Development Compliance Compliance Education 76

Cannabis Law Report

DECEMBER 16, 2021

The Centers for Disease Control and Prevention (CDC) published workplace guidance for creating marijuana policies and drug testing procedures for employed drivers, including education for drivers on marijuana’s effects on safe driving. Nevada Cannabis Compliance Board Takes Action for Tax Payment Failures.

Cannabinoids 52

Cannabinoids Retail Policy Cultivation 52

Cannabis Law Report

MARCH 21, 2022

The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes.

Business 52

Business Seed-To-Sale Research and Development Conditions 52

Cannabis Law Report

MAY 29, 2022

Fast Track review is for drugs that treat serious conditions and fill an unmet medical need. Sponsors should be aware that REMS with ETASU may increase compliance risk and limit commercial options. DEA classifies marijuana as a Schedule I substance, while at the same time researchers have long touted its potential medical benefits. [18]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

FEBRUARY 4, 2019

Leaf Data Systems Update. You can read more about product packaging and labeling requirements on the Understanding Board Interim Policies for Packaging and Labeling section of the LCB website. The policy only applies to approved owners who are investing their own personal money into the business. Leaf Data Systems Update.

Topical 65

Topical Packaging Retail Legislation 65

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: Full-time and seasonal Florida residents who suffer from an eligible medical condition. To qualify for medical marijuana in Florida, a patient must: Be diagnosed by a certified physician with a qualifying condition. Regular cannabis does not have to meet the same requirements. Who is eligible for medical marijuana?

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

JANUARY 31, 2019

Latest study designed to encourage sensible policy development. Oregon’s Public Policy Approach to Support Legal Marijuana Production and the State’s Abundant Supply: The Course for Seeking the Right Balance. Oregon’s current supply in the legal market is a reflection of successful policies to move production into the legal system.

Legislation 61

Legislation Recreational Marijuana Policy 61

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

Measure 1, Security plan: The applicant shall provide an acceptable safety and security plan, including staffing and site plan, and a detailed description of proposed security and safety measures, which demonstrates compliance with the rules at N.J.A.C. Ability to provide appropriate research data. Criterion 2.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 27, 2021

Closing of the Private Placement is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including approval of the Toronto Stock Exchange. Each whole Warrant will entitle the holder to acquire one additional Common Share at a price of USD$0.50 HempFusion Wellness Inc. Jason Mitchell, N.D.

Research and Development 105

Research and Development Events Hemp Food 105

Cannabis Law Report

JULY 20, 2019

Measure 1, Security plan: The applicant shall provide an acceptable safety and security plan, including staffing and site plan, and a detailed description of proposed security and safety measures, which demonstrates compliance with the rules at N.J.A.C. Ability to provide appropriate research data. Criterion 2.

Law 40

Law Marijuana Education Cultivation 40

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

OCTOBER 14, 2021

Smiths Falls, Ontario-based Canopy said the proposed acquisition is conditioned on “federal permissibility of THC in the U.S.”. multi-state operator, and the Company’s conditional ownership interest in TerrAscend Corp., 1 Source: Headset data for tracked US states. Canopy Growth has struck a deal to buy leading U.S.

Edibles 52

Edibles Data Marijuana Events 52

Cannabis Law Report

MARCH 30, 2020

Employers must attempt to balance public health concerns, compliance with emergency government orders, employee safety, consumer demand, and financial reality. Many states are enacting restrictions on business activity or even forcing “non-essential” companies to close or transition to a work-from home policy.

Marijuana 59

Marijuana Dispensary Patients Business 59

Cannabis Law Report

FEBRUARY 17, 2022

The Commission continues to actively monitor the licensee’s compliance with the conditions of the Order including the licensee’s Standard Operating Procedures relative to product recalls and notification to the public. To date, no related illnesses have been reported to the Commission.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Peninsula Alternative Health

MARCH 1, 2018

The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

Cannabis Law Report

MARCH 1, 2022

We are looking for a legal compliance analyst/paralegal to join our team. The role would include being responsible for researching and analysing compliance policies and procedures, as well as developing and managing the compliance training programmes, and being responsible for legal administrative tasks.

Compliance 52

Compliance Compliance Legalization Research and Development 52

Cannabis Law Report

SEPTEMBER 20, 2019

Data indicates cannabis-containing vaping products losing market share to other cannabis products after recently reported health concerns. Opioid dependency became a qualifying condition in June. The State Medical Board desires more research before agreeing to allow additional conditions. Today, vape sales account for 28.9

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis to treat ankylosing spondylitis and psoriatic arthritis among many other autoimmune conditions, mental health and the effects of chronic inflammation. Bad policy hurts Canadians; in Canada we don’t tax medicine and we don’t hurt those living with chronic illness.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

NOVEMBER 29, 2021

2 Data from Google Analytics. NuLeaf’s products are produced at a cGMP-certified facility enabling them to manufacture groundbreaking cannabinoid formulations while exceeding the highest levels of regulatory compliance. Garfinkle Biderman LLP and Sichenzia Ross Ference LLP acted for High Tide in connection with the Transaction.

Retail 52

Retail Cannabinoids Events Recreational 52

Cannabis Law Report

JUNE 23, 2021

1 Based on Canopy’s internal market share data. A copy of the early warning report of Canopy in connection with the acquisition of the Supreme Shares will be filed under Supreme’s profile on SEDAR and can be obtained by contacting Canopy at the number shown below. _.

Recreational 90

Recreational Events Collective Cultivation 90

Cannabis Law Report

OCTOBER 12, 2021

Since 2017, Jill has led the finance, administration and compliance oversight functions for Venom Extracts. He is known for an ability to build long term relationships, collaborate with stakeholders, and engage organizational grassroots to ensure legislative policy goals are met. Additional Information.

Extraction 52

Extraction Business Hash Events 52

Cannabis Law Report

JUNE 2, 2022

Many of the environmental harms from cannabis production can be traced to law enforcement policy and the marijuana plant’s historic status as a prohibited crop, according to Anthony Silvaggio, an environmental sociologist at Humboldt State University. Every additional use is important to consider and has incremental negative impacts.

Legalization 52

Legalization Cultivation Cannabis Environment 52

Cannabis Law Report

MAY 26, 2022

One of the most successful alcohol control policies in the United States was the establishment of the minimum legal drinking age of 21 (MLDA-21). All states have a version of MLDA-21, with Congress passing legislation in 1984 pressuring all states to enact the policy if they had not already done so. 1988, Jones et al.,

Dispensary 52

Dispensary Research and Development Safety Recreational 52

The Blunt Truth

JUNE 18, 2020

million settlement, based on the actions of a third party texting technology, is insufficient, and who was at the same time hit with another separate TCPA suit based on their current terms and conditions. As such, compliance with the TCPA was already difficult for even the most established industries and companies.

Compliance 95

Compliance Compliance Data Dispensary 95

Cannabis Law Report

JUNE 3, 2022

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. However, it is still impossible to quantify at this stage due to the uncertainty about new variants which may emerge and public policy responses.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

MARCH 1, 2022

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

SpeedWeed

MARCH 24, 2021

In the latest episode of the Cannacurio Podcast from Cannabiz Media, I speak with Tony Repanich, President and Chief Operating Officer of Shield Compliance , a comprehensive compliance management platform for banking cannabis-related businesses. Because there’s a lot of compliance issues in place here. Welcome, Tony.

Compliance 52

Compliance Compliance Banking Data 52

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

NOVEMBER 18, 2021

Changes in laws, regulatory measures, or governmental policies – especially those that affect the production, importation, marketing, labeling, pricing, distribution, sale, or consumption of our beverage alcohol products. Failure to comply with anti-corruption laws, trade sanctions and restrictions, or similar laws or regulations.

Supply Chain 52

Supply Chain Business Policy Consumption 52

Cannabis Law Report

JANUARY 25, 2022

Changes in laws, regulatory measures, or governmental policies – especially those that affect the production, importation, marketing, labeling, pricing, distribution, sale, or consumption of our beverage alcohol products. Failure to comply with anti-corruption laws, trade sanctions and restrictions, or similar laws or regulations.

Supply Chain 52

Supply Chain Policy Business Consumption 52